# A Genomic Approach for Clopidogrel in Caribbean Hispanics

> **NCT03419325** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Puerto Rico** · enrollment: 150 (actual)

## Conditions studied

- Cardiovascular Disease (CVD)
- Stroke
- Acute Coronary Syndrome
- Peripheral Arterial Disease
- Coronary Artery Disease
- Myocardial Infarction

## Interventions

- **GENETIC:** CYP2C19 test
- **DIAGNOSTIC_TEST:** P2RY12 assay

## Key facts

- **NCT ID:** NCT03419325
- **Lead sponsor:** University of Puerto Rico
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-01
- **Primary completion:** 2023-04-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419325, "A Genomic Approach for Clopidogrel in Caribbean Hispanics". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03419325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*